Fantastic paper from Thiago Cunha and gang implicating IDO producing meningeal dendritic cells in neuropathic pain. Congrats, guys! https://www.jci.org/articles/view/153805
Gathering real world data on the efficacy of drugs and vaccines used to treat or prevent #monkeypox is vital. Many where developed for #smallpox and approved via the FDA's "animal rule", which means that although the safety data is there, the efficacy is essentially unknown. I wrote a bit about this for #NatureMedicine in September when looking at the use of the #antiviral #tecovirimat for monkeypox.
'During the current outbreak of #monkeypox (recently renamed mpox), #smallpox #vaccination has been recommended to prevent mpox infection in persons who have had mpox exposure, but evidence to support this practice is limited.1,2 We conducted a study to evaluate potential breakthrough infections in participants who had received smallpox vaccine after high-risk exposure to mpox.'
In preprints: improving and interrogating embryo models
Antonio Scialdone and Nicolas Rivron discuss the fast developing field of embryo models, highlighting two preprints with new methods for ensuring reproducibility and investigating complexity.
"A better understanding of the relative contribution of IFN-γ–dependent and –independent pathways in resistance to #cryptosporidium is needed, and understanding which immune deficiencies lead to increased risk for cryptosporidiosis may offer clues as to the host pathways that restrict Cryptosporidium that may also be relevant to other enteric pathogens."
Why dont researchers use Open Data? One of the reasons: dont know how to find them
Help us change this by adding resources to (or using) EcoEvo catalogue https://ckan-ecoevo.d4science.org/ It lists aggregators you can use to find data, like WoS finds articles
more details on data reuse in https://doi.org/10.1038/s41559-017-0458-2
I would also love to hear from you. Do you find this resource useful? Why yes, why not? Would you like to do some further research on data finding with me? How can we improve the catalogue?
A little late, but here's our #introduction:
We are a research institute devoted to biomedical research. Our aim is to understand the molecular basis of health and disease - and to translate findings as quickly as possible into clinical applications. Better prevention, diagnosis and treatment of diseases are the ultimate goals.
#Genes
#Cells
#Molecules
#Proteins
#SystemsMedicine
#Cardio
#Biomedicine
#Diseases
#Health
'One answer is that as a country, we prefer just to not see those deaths at all, regarding a baseline of several hundred deaths a day as a sort of background noise or morbid but faded wallpaper. We don’t need to understand who is dying or why in part because we don’t want to reckon with the fact that around 300 Americans are now dying from Covid-19 every day, at a rough pace of about 100,000 per year, making it the country’s third leading cause of death. This is normalization at work, but it is also a familiar pattern: We don’t exactly track the ups and downs of cancer or heart disease either.'
https://www.nytimes.com/2022/12/07/opinion/environment/covid-19-pandemic-elderly-deaths.html
When asked by the occasional layperson whether there are everyday consequences of population-genetic processes, this paper may come handy to support one's answer
Thirty years ago, in November 1992, Ishida, Honjo and their collaborators reported the discovery of the #PD1 gene in @embojournal
https://www.embopress.org/doi/abs/10.1002/j.1460-2075.1992.tb05481.x
I spoke with Tasuku Honjo, Pierre Golstein (whose team first cloned #CTLA4) & Facundo Batista about the discovery earlier this year.
The initial project had absolutely nothing to do with checkpoints or #immunotherapy
Listen to the full #EMBOPodcast episode at the link below or on pretty much any podcast app
#Immunology #HistoryScience #Cancer #CellDeath
https://www.embo.org/podcasts/from-cell-death-to-cancer-immunotherapy/
'Prosecutors described Balwani as an “equal participant” in helping Theranos defraud investors of more than $900mn in funding — which gave the company a valuation of $9bn — on the promise its technology could carry out a range of tests on a single drop of blood.
Instead, the machines failed to perform as promised, as later revealed by whistleblowers, and the company entered a death spiral that has become symbolic of Silicon Valley’s risk-taking culture.'
#Theranos
https://www.ft.com/content/c456dfb5-34d2-4b65-a580-92b23181a358
RT @ScheiermannLab@twitter.com
Tumor growth is governed by the time of engraftment, which is controlled by the adaptive immune system; have a look at our circadian anti-tumor immune response paper: https://www.nature.com/articles/s41586-022-05605-0
🐦🔗: https://twitter.com/ScheiermannLab/status/1599860327096717339
Day8: Lordiphosa andalusiaca—Our first #Advent species not in #Drosophila: a distinctive #Fly with a striking colour #polymorphism (https://brill.com/view/journals/anz/17/2/article-p275_3.xml - ours is a dark one). Lordiphosa like rotting plants http://www.drosophila.jp/jdd/class/030704/03070441.pdf and some species have sex combs https://doi.org/10.1111/evo.14564 . It gives us two lessons in systematics: [1] #Drosophilid #Taxonomy doesn’t match #Phylogeny https://academic.oup.com/gbe/article/13/8/evab179/6337980 ; [2] Do not let people play word games with your (sub)genera... cf. Phloridosa & Siphlodora
RT @CarstenWMueller
10 days to go - PostDoc and PhD position in our #SoilScience group at @science_ku - work with us on #RootCarbon #RhizosphereFunctioning #Imaging #POM #MAOM #SoilCarbonStorage #RootTraits apply online:
PostDoc: https://employment.ku.dk/all-vacancies/?show=157831
PhD: https://employment.ku.dk/all-vacancies/?show=157854 @novonordiskfond
'The lack of doctors entering ID fellowships — and the ensuing shortage of these specialists — has been a concern for years, with experts pointing to the comparatively low earnings these physicians make as a major disincentive for doctors considering which field to enter. But this year’s numbers marked a backslide. Fully a quarter of available positions went unfilled. Among the fellowship programs, 44% didn’t fill their slots, according to data from the National Resident Matching Program.'
Really excited to launch @Dev_journal@twitter.com "Pathway to Independence Programme"
Are you, or do you know, a dev bio or stem cell researcher planning to apply for their 1st PI position in 2023?
Then this scheme is for you. See how to apply:
RT @Dev_journal@twitter.com
We're excited to announce a new scheme aimed at supporting postdocs as they go on the job market. Our 'Pathway to Independence' programme will provide mentorship, support and networking opportunities to a group of researchers transitioning to independence https://journals.biologists.com/dev/article/149/23/dev201456/285866/
🐦🔗: https://twitter.com/Dev_journal/status/1600461166437748740
Let’s make the science move to #mastodonmigration a definitive thing.
---
RT @cyrilpedia
The community is growing over there - I even have a range of science-Luis friends to choose from, with @lmvteixeira at
& @LuisMateusRocha at
@lmrocha
https://twitter.com/CyrilPedia/status/1600525806924595200
RT @francesarnold
#finally caught up with @CarolynBertozzi and Jennifer @doudna_lab #nobelweek #chemnobelles @NobelPrize
So ends a historic attempt at global health equity: The board of Gavi votes this week on ending #Covax, even though some Gavi-supported countries are at <20% Covid vaccine coverage. The average among Gavi-countries is 52%. And 37 middle-income countries would be cut off after a one-time infusion of cash to take over Covid vaccination on their own. Thanks to vaccine nationalism, Omicron and a series of missteps, demand for shots globally is minimal. https://www.nytimes.com/2022/12/06/health/covid-vaccines-covax-gavi.html?unlocked_article_code=I0gswX0sD7xUortbHHQaakgy94bVmymnrTOO1hgGFmEc3tcgVF-HNYVVGRKFS3P6vVBTTqbeozQSAjd6eRsVq5FiPBmDQPJAUJhiecgkIqyzrq07Gzg2JzwRJJUOF7dd1tgP6dqQnzJ_F1cXJL5W5908i4b5mL6Kgd2vrRGu6TL1LYOqCzpcpr6xlONVg1LjyCUVWhsCLF7WSXr1ZiLTTIxjBUa_5C2QKzUnbcTR0BaIBVRTB1b5K5eRZcfBIfZ5MuYllgMc0M8ArvoddQMGP3kHHo1tlU1q8uVIuBLnSJFZDxc-Hgdh8Rnke_e9LDhUNgFeo6z_pWSMHZVmeir_RW_naQ&smid=share-url
I've worked on all of science, from B cells to T cells.
https://fellowsherpa.com